BALTIMORE — The Maryland-based vaccine maker Emergent BioSolutions was forced to destroy nearly 400 million doses of COVID-19 vaccine because of potential contamination at its East Baltimore plant, far more than previously known.
Further, the company sought to hide deficiencies from federal and outside inspectors at the site, built with millions of dollars of federal support, and continued to promote its manufacturing capabilities despite warnings of those deficiencies.
This is according to a final report expected to be released Tuesday after a year-long investigation by the House of Representatives’ Select Subcommittee on the Coronavirus Crisis, a panel that previously found significant flaws in the Trump-era deal to pay Emergent hundreds of millions to make vaccine.
